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Purpose: The aim of this study was to evaluate the effect of surgical repair of pel-
vic organ prolapse on female sexual function and to assess correlations between 
the two using two current standardized questionnaires. Materials and Methods: 
From October 2009 to September 2010, 143 patients with posterior compartment 
or combined vaginal prolapse were included. We assessed surgical outcomes ac-
cording to anatomical change in the vagina and results of the Female Sexual Func-
tion Index (FSFI) and Pelvic Organ Prolapse/Urinary Incontinence Sexual Func-
tion questionnaire (PISQ-12) both pre- and postoperatively. Results: Among the 
143 preoperative patients, 99 and 84 patients responded to the PISQ-12 and FSFI, 
respectively. The mean PISQ-12 score increased after surgery (p<0.001). Specifi-
cally, postoperative scores for questions 8 and 12 were higher than their respective 
preoperative scores (p<0.001). Postoperatively, mean FSFI score changed only 
slightly (p=0.76), and only the score for the satisfaction domain was improved 
(p=0.023). In regards to vaginal anatomy, vaginal length was significantly greater 
postoperatively (6.99±0.18 vs. 7.56±1.08, p<0.001), and postoperative vaginal cal-
iber was narrowed to a two-finger width. Conclusion: In this study, surgery for 
pelvic organ prolapse was shown to affect female sexual function. Moreover, 
menopause was associated with a change in postoperative sexual function.
Key Words:   Pelvic organ prolapse, sexual function, female sexual dysfunction, Fe-
male Sexual Function Index, Pelvic Organ Prolapse/Urinary Inconti-
nence Sexual Function questionnaire 
INTRODUCTION
Sexual well-being is an important aspect of women’s health, and dysfunction there-
of has been shown to lead to a decreased quality of life. Sexual dysfunction among 
women has been reported to be highly prevalent in up to 50% of women,1 and dis-
orders of desire, arousal, lubrication, and orgasm as well as dyspareunia are typical 
complaints reported by women.2 Furthermore, several factors, including relation-
ship conflicts, socioeconomic status, sexual compatibility, and physical and psychi-
atric disorders can affect sexual function.3-5 Pelvic floor weakness and organ pro-
lapse are common physical conditions that negatively affect sexual function and 
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ed information on their general medical and sexual history. 
In this study, the Female Sexual Function Index (FSFI) 
and Pelvic Organ Prolapse/Urinary Incontinence Sexual 
Function questionnaire (PISQ-12) were administered to 
evaluate sexual function. Patients were required to com-
plete the Korean version of questionnaires translated from 
English prior to and after undergoing surgery. Postoperative 
assessment was carried out 36 weeks after the operation. 
The questionnaire was self-administered; beforehand, the 
interviewer thoroughly explained each questionnaire and all 
questions. Total 4 cases (4.7% vs. 4%) couldn’t report by 
themselves because of their illiteracy. In cases where the in-
terviewee was unable to read or write, the interviewer just 
read the questions aloud and recorded the patient’s reply to 
limit bias. All questionnaires were surveyed by the same in-
terviewer. Questionnaires that contained responses to all 
items were evaluated, whereas questionnaires with blanks 
were excluded from the evaluation. 
Standardized questionnaires including FSFI and PISQ-12 
were utilized to assess sexual function in women with pel-
vic organ prolapse. The FSFI is a 19-item survey that as-
sesses six domains of female sexual dysfunction (FSD). 
Scores range of the FSFI from 2 to 36.0; a total score of 
26.55 or less is suggestive of FSD and individual domain 
scores of less than 3.6 are considered dysfunction.14 The 
FSFI assesses sexual function over the previous six months 
and has been confirmed for the Diagnostic and Statistical 
Manual of Mental Disorders IV diagnoses of FSD including 
hypoactive sexual desire disorder, female sexual arousal dis-
order, and female sexual orgasmic disorder.15 
In contrast, the original PISQ comprises 31 questions in-
cluding three domains to be reflective of sexual function 
over the previous four weeks: behavioral-emotive, physi-
cal, and partner-related.16 The first domain, the behavioral-
emotive session, examines the frequency of sexual activity, 
the desired frequency, orgasm rates, and satisfaction with 
one’s sexual relationship.16,17 In second, episodes of pain, 
incontinence, sensation of prolapse, and fear of fecal and/or 
urinary incontinence during sexual activity are included the 
physical domain.16,17 The partner-related domain lastly mea-
sures any difficulty with erectile dysfunction, premature 
ejaculation, vaginal attenuation, vaginal tightness or the pa-
tient’s perception of a partner’s avoidance of intercourse.16,17 
Among of 31 questions, PISQ-12 were made of the most 
validated 12 questions only as short form.17  
Our study examined changes in sexual function based on 
patient responses to these questionnaires following surgery 
satisfaction.4,5 Pelvic organ prolapse occurs in greater than 
50% of parous women over 50 years of age and poses a life-
time risk of 30-50%.6 Patients with clinically significant pel-
vic organ prolapse usually complain of a vaginal bulging 
sensation accompanied by symptoms of bladder, bowel, or 
sexual dysfunction.7  
To treat pelvic organ prolapse, both surgical and nonsurgi-
cal modalities are available. Conservative treatment options, 
including observation, pelvic floor exercises, and vaginal 
pessaries, usually in combination with local estrogen,2 are 
recommended before turning to surgical treatment, even 
though there are 20-40% rate of re-operation for prolapse 
of the anterior compartment, 5-20% for the posterior com-
partment, and up to 30% for the apical compartment.8 Al-
though most cases are managed surgically,9 earlier studies 
have shown contradictory results: a few authors reported 
that surgical treatment of pelvic floor weakness and pelvic 
organ prolapse improves sexual function postoperatively,10 
while others reported worsening of sexual function.11,12 
The aim of this study was to compare the effect of surgi-
cal repair of pelvic organ prolapse on female sexual func-
tion with the results of two different standardized question-
naires administered to Korean women.  
MATERIALS AND METHODS
　　　
Between October 2009 and September 2010, we asked all 
patients scheduled to undergo surgery for International Con-
tinence Society Pelvic Organ Prolapse Quantification (ICS 
POP-Q) stage II-IV pelvic organ prolapse13 at Yonsei Uni-
versity Severance Hospital to participate in this study. Our 
study was approved by the hospital’s Institutional Review 
Board, and all patients provided informed consent to partici-
pate in the study. Preoperative and postoperative pelvic as-
sessments were performed by the same surgeon according to 
the ICS POP-Q staging system. In this study, patients with 
posterior compartment or combined vaginal prolapse who 
required posterior colporrhaphy and perineorrhaphy were 
enrolled. Patients with prolapse of the anterior or superior 
compartments only and those who did not respond to the 
questionnaires were excluded. Preoperative and postopera-
tive subjective urinary, coital, and bowel symptoms were 
assessed by interview. All enrolled patients underwent a 
physical examination, including gynecologic examination 
and preoperative urodynamic measurements to evaluate oc-
cult stress urinary incontinence (SUI). Patients also provid-
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test were used to evaluate categorical data. A covariance 
mixed model was used to control for confounding variables 
in the analysis of PISQ-12 score, FSFI score and individual 
factors. These were evaluated with SAS software (version 
9.2, Cary, NC, USA).  
 
RESULTS
 
In total, 143 women with a mean age of 65.13±9.99 years 
were included in the study. A total of 84 patients completed 
the FSFI and 99 patients completed the PISQ-12. The base-
line demographic and clinical parameters of the patients are 
shown in Table 1. In this study, the primary outcome was 
change in vaginal anatomy including total vaginal length 
(TVL) and genital hiatus (GH). To compare changes in 
vaginal anatomy, TVL and GH measurements were taken 
preoperatively and six months after surgery at our outpa-
tient clinic by the same surgeon. GH was defined as the 
largest diameter at the introitus. TVL was defined as the 
distance from the tip of the ringed forceps at the vaginal 
apex to the posterior vaginal introitus. Postoperatively, total 
vaginal length increased from 6.99±0.19 cm to 7.56±1.08 
cm in TVL (p<0.001) and genital hiatus narrowed from 
5.01±0.98 cm to 3.00 cm (p<0.001). 
The secondary outcome was the difference between preop-
erative and postoperative FSFI and PISQ-12 scores. The total 
FSFI score was 8.53±9.5 before surgery and 11.02±9.7 at 6 
months after surgery (p=0.08), and only the satisfaction do-
main score significantly increased (p=0.029). In our study, 82 
of 84 cases (97.6%) were classified as having FSD with a 
score of 26.55 on FSFI. The results of the FSFI indicated that 
satisfaction was improved (Table 2). The mean preoperative 
PISQ score changed from 25.0±4.95 to 28.33±5.1 postopera-
tively (p<0.001); more specifically, postoperative scores for 
questions 8 (q8) (Do you avoid sexual intercourse because 
of bulging in the vagina?) and 12 (q12) (Compared to or-
gasms you have had in the past, how intense are the or-
gasms you have had in the past six months?) were higher 
than their respective preoperative scores (p<0.001). In other 
words, patients reported that they were less likely to avoid 
sexual intercourse due to vaginal prolapse (q8) (1.79 vs. 
3.76 postoperatively, p<0.01) after surgery. The orgasm 
score (q12) on the PISQ-12 was also increased after surgery 
(0.69 vs. 1.58, p<0.01); however, results indicated that or-
gasm intensity was the same after surgery, corresponding to 
a score of approximately 2 (Table 3). No correlation among 
for pelvic organ prolapse. Furthermore, after a systemic 
search on MEDLINE (search terms: “sexual function in-
cluding the FSFI and the PISQ-12 for surgically treated pel-
vic organ prolapse/urinary incontinence”, in all languages, 
from 1970 to 2010), several studies reporting on sexual 
function after prolapse repair were found and included in 
our analysis if they employed the FSFI or PISQ-12. 
Statistical comparisons were made using the Wilcoxon 
signed-rank test for vaginal anatomy, each domain of sexu-
al function, and changes in FSFI and PISQ-12 scores. SPSS 
software version 19.0 (SPSS Inc., Chicago, IL, USA) was 
used to analyze the data. p<0.05 was considered to be sta-
tistically significant. A correlation analysis and chi-square 
Table 1. Baseline Demographic and Clinical Parameters of 
Patients
  Variables Sample (n=143) 
Age (yrs) 65.13±9.99* 
BMI (kg/m2) 24.21±3.04* 
Weight (kg)   58.1±7.96*
Parity     3 (2-8)† 
Menopause 131 (91.6%)
Hormonal replacement therapy     9 (6.3%)
Alcohol     3 (2.1%) 
Smoking     1 (0.7%)
Concomitant SUI   31 (21.7%) 
Married/widowed 122/21 (86.7%/14.3%) 
Diabetes 27 (18.9%) 
Hypertension 88 (61.5%)
Dyslipidemia (n=56) 16 (28.6%) 
Metabolic syndrome (n=104) 21 (20.2%)
Preoperative prolapse stage (n) 
    II 10 (7%)
    III 92 (64.3%) 
    IV 41 (28.7%) 
Previous hysterectomy (n) 15 (10.4%) 
Previous pelvic reconstruction (n) 11 (7.7%)
Surgery performed (n)  
    Posterior colporrhaphy & 
      perineorrhaphy only
40 (28.0%) 
    Other surgery with posterior 
      colporrhaphy & perineorrhaphy 
        Anterior colporrhaphy 89 (62.2%) 
        Iliococcygeal colposuspension   4 (2.8%)
        Vaginal hysterectomy 52 (36.4%)
        Abdominal hysterectomy 14 (9.7%) 
        Sacrocolpopexy 23 (16%) 
        Concomitant transobturator tape 31 (21.7%) 
BMI, body mass index; SUI, stress urinary incontinence.
*Mean±SD.
†Median.
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menopause, smoking and hormonal replacement therapy 
(HRT). Q1 to q12 were affected by cofactors including par-
ity, menopause, metabolic syndrome, HRT, etc. Concomi-
tant SUI affected a variety of sexual activities (q4) and leak-
age of urine during sexual activity (q6), but it did not affect 
the change in the total score (Table 3 and 5). In the adjust-
ment model, menopause was the only cofactor shown to af-
fect postoperative sexual function (Table 6 and 7).
the scores of the PISQ-12, FSFI and pelvic organ prolapse 
stage (Table 2 and 3) was observed.  
Statistical analysis was performed to identify cofactors af-
fecting these results. Correlations between each domain of 
the FSFI and PISQ-12 as well as patient variables were as-
sessed using univariate analysis and a covariance patterned 
model. On the FSFI, the desire and arousal domains were 
related to parity, menopause, weight and body mass index 
(BMI). Lubrication and orgasm were related to menopause, 
weight and BMI. Satisfaction was associated with meno-
pause and weight. Parity, menopause, previous hysterecto-
my and concomitant SUI affected the pain domain. Overall 
scores were related to parity, menopause, weight and BMI 
(Table 4). On the PISQ-12, overall score was influenced by 
Table 2. Pre- and Postoperative FSFI Scores 
Domain 
Preoperative 
(n=84) 
Postoperative 
(n=84) 
p value 
Desire 1.79±0.88   1.88±0.89   0.448
Arousal 1.13±1.57   1.47±1.67   0.129
Lubrication 1.50±2.16   1.81±2.21   0.168
Orgasm 1.11±1.66   1.49±1.80   0.099
Satisfaction 1.65±1.28   2.03±1.50     0.029*
Pain 1.63±2.41   2.09±2.44   0.172
Total 8.52±9.56 11.01±9.72 0.08
FSFI, Female Sexual Function Index.
Data presented as mean±SD, p<0.05 is considered significant.
*p value <0.05 (Wilcoxon signed-rank test).
Table 3. Baseline and Postoperative PISQ-12 Scores 
Domain 
Preoperative 
(n=99) 
Postoperative 
(n=99) 
p value
q1 0.74±0.77   0.77±0.78 0.59
q2 0.85±0.90   0.89±0.93 0.61 
q3 0.97±1.01   1.02±1.03 0.45 
q4 0.81±0.92   0.87±0.92 0.39 
q5 3.26±0.90   3.11±1.19 0.17
q6 3.40±0.84   3.47±0.76 0.21 
q7 3.45±0.84   3.55±0.76 0.13
q8 1.79±1.56   3.16±1.32   <0.001*
q9 3.18±1.05   3.40±0.97 0.05
q10 3.23±1.02   3.19±1.14 0.78
q11 3.19±1.02   3.27±1.03 0.19
q12 0.69±1.02   1.58±1.14   <0.001*
Total 25.0±4.95 28.33±5.1   <0.001*
PISQ-12, Pelvic Organ Prolapse/Urinary Incontinence Sexual Function 
questionnaire.
Data presented as mean±SD, p<0.05 is considered significant.
*p value <0.05 (Wilcoxon signed-rank test).
Table 4. Cofactor Effect on FSFI (Covariance Patterned Model) (Pr>F value) 
Desire Arousal Lubrication Orgasm Satisfaction Pain Total
Parity 0.0236* 0.04528   0.0593 0.0521 0.0115* 0.03* 0.0347*
Menopause 0.0049* 0.0021* <0.00001* 0.0031 0.0002* 0.0008* 0.0002*
Alcohol 0.023 0.2813 0.2644 0.1869 0.3304 0.2826 0.2010
Smoking 0.1635 0.6181 0.1476 0.2444 0.1685 0.4866 0.2635
Dyslipidemia 0.5585 0.9612 0.9129 0.9132 0.9965 0.3397 0.7626
Metabolic syndrome 0.3763 0.7633 0.545 0.2462 0.7989 0.7885 0.7221
HRT 0.611 0.5567 0.473 0.4773 0.5315 0.282 0.4381
DM 0.1003 0.7258 0.9618 0.7248 0.6267 0.875 0.7125
HTN 0.9519 0.7347 0.4461 0.368 0.8786 0.649 0.8278
Height 0.1902 0.1529 0.4092 0.3675 0.0696 0.2091 0.1535
Weight 0.0011* 0.0023 0.0024 0.0045* 0.0244* 0.1478 0.0071*
BMI 0.0042* 0.015 0.0158 0.0091* 0.217 0.4641 0.0472*
Prior hysterectomy status 0.1994 0.1372 0.2345 0.1264 0.2095 0.0271* 0.1123
Prior pelvic reconstructive 
  surgery
0.0588 0.0914 0.1689 0.2462 0.3415 0.199 0.144
Stage 0.3418 0.7559 0.9122 0.8394 0.9321 0.9176 0.8945
Concomitant SUI 0.1692 0.1093 0.0831 0.1692 0.1553 0.0428* 0.0766
HRT, hormonal replacement therapy; DM, diabetes mellitus; HTN, hypertension; BMI, body mass index; SUI, stress urinary incontinence; FSFI, Female 
Sexual Function Index.
*Pr>F value<0.05.
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DISCUSSION
FSD is a common problem among the general population, 
and especially in pelvic organ prolapse patients. In the litera-
ture, a few studies are found to have evaluated the impact of 
pelvic floor surgery on FSD,18 however, significant contro-
versy remains as the actual benefits thereof.19 While some 
authors reported normal or even improved sexual activity 
following pelvic organ prolapse surgery, other authors report-
ed no difference or worsening of sexual function.2,6,11,12,20 In 
fact, recent studies have clearly shown that there are no dif-
ferences in sexual function between patients with and with-
out pelvic floor disease, including urinary incontinence and/
or pelvic organ prolapse, with over 81% of sexually active 
women with prolapse defining their sexual relations as “very 
satisfactory”.2,6,20 
For patients affected by pelvic organ prolapse, the goals 
of pelvic reconstructive surgery are to maintain the natural 
vaginal axis and to restore the original vaginal structure in-
cluding vaginal length, vaginal orifice and perineum. In our 
study, vaginal anatomy, consisting of vaginal length, peri-
neal body and orifice width, was about the same after pel-
vic reconstructive surgery. These findings made our points 
clear on the association between cofactors and female sexu-
al function postoperatively. 
In the literature, earlier reports describe worsening of 
pain.11,20 Narrowing of the vaginal orifice can occur with 
colporrhaphy and can lead to de novo dyspareunia even if 
there is an improvement in sexual function.20 However, the 
pain domain in this study was unchanged postoperatively. 
Hoda, et al.21 reported that worsening of pain during inter-
course throughout the initial postoperative period lessened 
after three months as healing progressed; moreover, dyspa-
reunia peaked three months after surgery and then decreased. 
In this study, we expected that patients responding at six 
months after surgery would complain of dyspareunia. Due 
to the time period during six months covered by the survey 
and the patients’ ability to recall, FSFI responses reflected a 
reduction in dyspareunia and PISQ-12 responses reflected 
only relief of pain. Concomitant anti-incontinence surgery 
can deteriorate some sexual domains. Transobturator tape 
may affect an orgasmic domain because it is able to pass 
the obturator foramen through the dorsal nerve of the clito-
ris.22,23 For this procedure, vaginal dissection may damage 
the distal perineal and cavernous nerves, negatively affect-
ing the innervation of the clitoris and altering its sensitivity.24 Ta
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might be considered a treatment of concomitant urinary in-
continence. However, efficacy of these alternative treat-
ments is controversial.29-32 Therefore, it is not yet considered 
to be the first line therapy for anti-incontinence surgery. 
Increasing age is known to be related to a reduction in 
sexual activity and decreased availability of partners.6 As 
older age is generally associated with FSD, differences in 
mean age in prior studies have made comparisons between 
studies imprecise. The population in the present study was 
significantly older than the population studied by previous 
authors.13-17 Preoperative FSD was diagnosed in 82 out of 
84 (97.6%) patients based on a score of 26.55 or below on 
FSFI. The proportion with FSD in the present study was 
much higher than that in other studies.13-17 In our study, the 
number of patients with FSD postoperatively was same as 
that preoperatively. Similar to Barber, et al.,4 pelvic recon-
struction did not change the number of patients who were 
sexually active. We also found menopause to be a cofactor of 
Other studies reported that anti-incontinence surgeries could 
damage vascular structures, alter normal vaginal anatomy, 
induce scarring, and reduce the elasticity of vaginal wall, 
causing dyspareunia.25,26 In our study, concomitant anti-in-
continence procedures were revealed to be a cofactor of q4 
(a variety of sexual activities) and q6 (leakage of urine dur-
ing sexual activity) despite no statistical improvement to 
each item. Interestingly, sling procedures could affect dys-
pareunia as cofactor without change of total score on the 
FSFI. In summary, sexual function scores as measured by 
FSFI and PISQ-12 were unchanged following pelvic recon-
structive surgery with or without anti-incontinence surgery, 
despite improvements in the stage of prolapse incontinence 
symptoms. Recent studies found that sexual function was 
unchanged following reconstructive surgery with or with-
out a surgical procedure for concomitant SUI.27,28 For the 
sexual function, alternative therapy including botulinum 
toxin injection or periurethral injection with bulking agent 
Table 6. Test of Fixed Effect on Multivariate Analysis (FSFI) (Pr>F value)
Desire Arousal Lubrication Orgasm Satisfaction Pain Total
Parity 0.0548 0.051 0.2018 0.1143 - 0.1615 0.0673
Menopause   0.0182*     0.0051* <0.0001*   0.0081*   0.0005*   0.0024*   0.0005*
Weight 0.3379   0.1526 0.4083 0.5219 0.1568 0.0328 0.7361
BMI 0.8359   0.1233 0.8751 0.8737 - - -
Prior hysterectomy status - - - - -   0.0328* -
Prior pelvic reconstructive surgery 0.0513   0.005* - - - - -
Concomitant SUI - - 0.0717 - -   0.0273*   0.0413*
BMI, body mass index; SUI, stress urinary incontinence; FSFI, Female Sexual Function Index.
-: NS.
*Pr>F value<0.05. 
Table 7. Test of Fixed Effect on Multivariate Analysis (PISQ-12) (Pr>F value)
q1 q2 q3 q4 q5 q6 q7 q8 q9 q10 q11 q12 Total
Parity 0.356 0.546 0.1963 0.655 0.2925 0.0065 - - - - - - -
Menopause 0.7835 0.0272* 0.7836 0.5975 0.1552 - - - 0.3914 - - - <0.0001*
HRT - - - - - - 0.0017 - - - 0.1615 - -
Smoking - - - - 0.0117* - 0.004* - - - - - -
HDL 0.0422* 0.0102* 0.0341* - 0.3146 - - - 0.0861 - - - -
LDL - 0.0101* - 0.9004 - 0.0065 - - 0.1333 0.0288* - - -
Weight 0.216 - 0.216 0.4722 - 0.4539 0.3292 - 0.7515 0.254 - - -
BMI - - 0.6839 0.4936 - - - - - 0.107 0.1835 -   0.0913
Prior hysterectomy 
  status
0.2086 - 0.0181* 0.1518 - 0.0541 0.0645 - - - - - -
Prior pelvic 
  reconstructive surgery
- - - - - - - - - - - - -
Concomitant SUI - - 0.0298* 0.1636 0.546 0.0397* 0.0454* - - - - - -
HRT, hormonal replacement therapy; HDL, high density lipid; LDL, low density lipid; BMI, body mass index; SUI, stress urinary incontinence; PISQ-12, Pelvic 
Organ Prolapse/Urinary Incontinence Sexual Function questionnaire.
-: NS.
*Pr>F value<0.05.
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